Various pharmaceutical products for systemic use

Description du marché

The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Ephedrine hydrochlorid 3 mg/ml (10 ml, i.v. solution, ATC C01CA26) - Parenteral products (intravenous administration) - Active pharmaceutical ingredient: Ephedrine hydrochlorid - Strength: 3 mg/ml - Pharmaceutical form: 10 ml, i.v. solution, vial/ampoule The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the articles is described in Annex 1. Quantity for the Article is described in Annex 7 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of June 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Article. The Contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.

Pouvoir adjudicateur